ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” third-quarter ...

Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release third quarter 2025 financial results before the market opens on Monday, ...

Vertex Inc. (NASDAQ:VERX) is a technology company that provides enterprise tax technology solutions for the retail, wholesale ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $408.85, marking a +1.15% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.06%. Elsewhere, the Dow ...

Vertex Pharmaceuticals (VRTX) closed at $403.30 in the latest trading session, marking a -1.36% move from the prior day. This change lagged the S&P 500's 0.01% gain on the day. On the other hand, the ...

Cryptocurrency analyst and trader Kevin Svenson says the price of Bitcoin (BTC) is on the cusp of accelerating upwards ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...